Biochips Market is projected to expand at a steady CAGR over the forecast period 2017
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Fluidigm Corpor<strong>at</strong>ion<br />
General Electric Company<br />
Bio-Rad Labora<strong>to</strong>ries Inc.<br />
bioMérieux SA<br />
Cellix Ltd.<br />
DNA chips segment domin<strong>at</strong>ed <strong>the</strong> global biochips market in 2016. Th<strong>is</strong> market<br />
dominance can be <strong>at</strong>tributed <strong>to</strong> <strong>the</strong> extensive adoption of DNA chips for detection and<br />
diagnos<strong>is</strong> of various genetic d<strong>is</strong>eases along with increased focus on research rel<strong>at</strong>ed <strong>to</strong><br />
next-gener<strong>at</strong>ion sequencing and genomics. With rapid adoption of diagnostic lab-on-a-chip<br />
(LOAC) and DNA analys<strong>is</strong> for point-of-care diagnostics and drug d<strong>is</strong>c<strong>over</strong>y applic<strong>at</strong>ions,<br />
<strong>the</strong> global biochips market will experience robust growth during <strong>the</strong> <strong>forecast</strong> <strong>period</strong>. Drug<br />
d<strong>is</strong>c<strong>over</strong>y and development segment held a major share of <strong>the</strong> biochips market in 2016 as<br />
biochips are being increasingly adopted for developing highly specific drug molecules and<br />
new chemical entity (NCE) drugs for <strong>the</strong> tre<strong>at</strong>ment of various d<strong>is</strong>eases. <strong>Biochips</strong> can<br />
considerably reduce <strong>the</strong> cost of drug d<strong>is</strong>c<strong>over</strong>y and aid in improving drug safety and hence<br />
are being widely adopted by biotechnology and pharmaceutical companies for drug<br />
d<strong>is</strong>c<strong>over</strong>y applic<strong>at</strong>ions.<br />
Two major technologies used for fabric<strong>at</strong>ing biochips involve microarrays and<br />
microfluidics. A microarray <strong>is</strong> a silicon chip or a glass slide which cons<strong>is</strong>ts of an array of<br />
molecules such as polypeptides, clones, oligonucleotides and antibodies. These molecules<br />
used are primarily used for gene expression and simultaneous examin<strong>at</strong>ion of rel<strong>at</strong>ionship<br />
between different genes. Microfluidics <strong>is</strong> a technology which involves micro-channels<br />
segmented on glass or a silicon substr<strong>at</strong>e. Th<strong>is</strong> technology has various biomedical<br />
applic<strong>at</strong>ions th<strong>at</strong> include immunoassays, drug d<strong>is</strong>c<strong>over</strong>y, capillary electrophores<strong>is</strong> and cell<br />
biology research.<br />
Make Inquiry about Report: https://www.crystalmarketresearch.com/send-anenquiry/SE09229<br />
<strong>Market</strong> Opportunities<br />
With high prevalence of cancer and o<strong>the</strong>r chronic d<strong>is</strong>eases worldwide, <strong>the</strong> need for<br />
advanced drug development altern<strong>at</strong>ives <strong>is</strong> increasing significantly in all parts of <strong>the</strong><br />
world. Emerging markets such as Asia-Pacific are expected <strong>to</strong> offer significant growth<br />
opportunities for <strong>the</strong> global biochips market in coming years as expenditure on advanced<br />
research <strong>is</strong> r<strong>is</strong>ing considerably in developing countries such as China and India.<br />
<strong>Biochips</strong> <strong>Market</strong> Segment<strong>at</strong>ion:<br />
By Product:<br />
<br />
<br />
<br />
<br />
<br />
DNA Chips<br />
Protein Chips<br />
Lab-on-a-chip<br />
T<strong>is</strong>sue Arrays<br />
Cell Arrays<br />
2 | P a g e
Change language